Key pathways like hedgehog (35) and TGF-β (36) are involved in these processes, contributing to conditions like non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC) (37). Here, TGFB1 is linked to metabolic dysfunction-associated steatohepatitis.